GROUP ONE TRADING, L.P. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$9,000
-10.0%
17,722
+145.4%
0.00%
Q1 2019$10,0007,222
+120266.7%
0.00%
Q4 2018$06
-72.7%
0.00%
Q3 2018$0
-100.0%
22
-100.0%
0.00%
-100.0%
Q2 2018$322,000
+585.1%
90,131
+483.9%
0.00%
Q1 2018$47,000
-89.4%
15,435
-78.0%
0.00%
-100.0%
Q4 2017$442,000
-46.7%
70,178
-42.2%
0.00%
-62.5%
Q3 2017$830,000
+325.6%
121,364
+471.1%
0.01%
+300.0%
Q1 2017$195,000
+4775.0%
21,250
+1987.4%
0.00%
Q4 2016$4,000
-96.7%
1,018
-96.8%
0.00%
-100.0%
Q3 2016$122,000
-52.9%
31,929
-47.0%
0.00%
-66.7%
Q2 2016$259,000
-25.4%
60,277
-19.5%
0.00%
-40.0%
Q1 2016$347,000
-27.1%
74,840
+57.6%
0.01%
-16.7%
Q4 2015$476,000
-49.0%
47,482
+141.1%
0.01%
-53.8%
Q2 2015$934,000
+178.0%
19,696
+114.7%
0.01%
+160.0%
Q1 2015$336,000
+57.7%
9,172
+71.0%
0.01%
+66.7%
Q4 2014$213,000
+42.0%
5,364
-51.6%
0.00%
+50.0%
Q2 2014$150,000
+38.9%
11,093
+11.4%
0.00%0.0%
Q1 2014$108,0009,9560.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2019
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 293,675$14,061,0004.76%
BB BIOTECH AG 1,507,114$71,497,0001.94%
SECTORAL ASSET MANAGEMENT INC 893,076$42,368,0001.77%
Opaleye Management Inc. 65,000$3,084,0001.23%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 390,294$18,515,0001.14%
Granite Point Capital Management, L.P. 75,206$3,568,0001.04%
Granahan Investment Management 705,601$33,474,0000.95%
Iguana Healthcare Management, LLC 50,000$2,372,0000.75%
Eventide Asset Management 290,000$13,758,0000.74%
Rhenman & Partners Asset Management AB 107,400$5,095,0000.61%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders